4.7 Article

European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe

期刊

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 66, 期 8, 页码 1897-1905

出版社

OXFORD UNIV PRESS
DOI: 10.1093/jac/dkr190

关键词

antiviral agents; drug consumption; pharmacoepidemiology

资金

  1. DG SANCO of the European Commission [2003211]
  2. ECDC [2007/001]

向作者/读者索取更多资源

Objectives: To assess the total systemic antiviral use in Europe and to identify the antiviral substances most commonly used. Methods: Within the European Surveillance of Antimicrobial Consumption (ESAC; www.esac.ua.ac.be), using the anatomical therapeutic chemical (ATC) classification and defined daily dose (DDD) measurement unit, data on total (out- and inpatient) systemic antiviral use (ATC J05), aggregated at the level of the active substance, were collected for 2008, and use was expressed in DDD (WHO ATC/DDD, version 2010) per 1000 inhabitants per day (DID). Antiviral substances were grouped according to their main indication. Results: In Europe, 12 countries (Belgium, Croatia, Denmark, Estonia, Finland, France, Hungary, Italy, Luxembourg, Russia, Slovenia and Sweden) provided total (out- and inpatient) data and 4 countries (Austria, the Netherlands, Portugal and Norway) provided outpatient data only. Total systemic antiviral use varied by a factor of 10.95 between the country with the highest (3.53 DID in France) and the country with the lowest (0.32 DID in Croatia) use. HIV/AIDS antivirals represented more than 50% of the total antiviral use in most countries. The amount and spectrum of antivirals used varied greatly between countries. Conclusions: Our study demonstrated a wide variation of total systemic antiviral use in several European countries, as striking as that of outpatient systemic antibiotic, antimycotic and antifungal use. The variation is mainly determined by the use of HIV/AIDS antivirals. These observations should stimulate further analysis to understand the variation of specific antiviral substances. The ESAC data facilitate auditing of antiviral prescriptions and evaluation of the implementation of guidelines and public health policies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Case Report on Pulmonary Involvement in a Patient with Adult Still's Disease

Leonid Dvoretsky, Anna Torgashina, Svetlana Rachina, Nelli Dubrovskaya, Girindu Hewathanthirige

Summary: This case report describes a 45-year-old male patient with Adult Still's Disease and pulmonary involvement. The patient presented with continuous fever, failure to respond to antibiotics, skin rashes, musculoskeletal syndrome, and pharyngitis. Lung examination revealed bronchopulmonary lymphadenopathy, interstitial changes, and dense foci, while laboratory tests showed neutrophilic leukocytosis, elevated ALT, AST, and inflammatory markers. Treatment with methylprednisolone and methotrexate led to the complete regression of symptoms and normalization of laboratory tests, as well as partial regression of the lung findings on CT scan.

CURRENT RHEUMATOLOGY REVIEWS (2023)

Article Pharmacology & Pharmacy

Added value of patient- and drug-related factors to stratify drug-drug interaction alerts for risk of QT prolongation: Development and validation of a risk prediction model

Katoo M. M. Muylle, Sven van Laere, Luigi Pannone, Samuel Coenen, Carlo de Asmundis, Alain G. G. Dupont, Pieter Cornu

Summary: By developing and validating a risk prediction model considering patient- and drug-related factors, the QT-DDI alerting was significantly improved, leading to more appropriate stratification with increased accuracy and precision.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Economics

Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries

Xiao Li, Joke Bilcke, Alike W. van der Velden, Robin Bruyndonckx, Samuel Coenen, Emily Bongard, Muirrean de Paor, Slawomir Chlabicz, Maciek Godycki-Cwirko, Nick Francis, Rune Aabenhus, Heiner C. Bucher, Annelies Colliers, An De Sutter, Ana Garcia-Sangenis, Dominik Glinz, Nicolay J. Harbin, Katarzyna Kosiek, Morten Lindbaek, Christos Lionis, Carl Llor, Reka Miko-Pauer, Ruta Radzeviciene Jurgute, Bohumil Seifert, Par-Daniel Sundvall, Pia Touboul Lundgren, Nikolaos Tsakountakis, Theo J. Verheij, Herman Goossens, Christopher C. Butler, Philippe Beutels

Summary: This study aimed to evaluate the cost-effectiveness of adding oseltamivir to primary care in Europe for treating influenza-like illness (ILI) in adults/adolescents and children. The results showed that adding oseltamivir to primary care is likely to be cost-effective from the healthcare payers' perspective, and cost-saving from a societal perspective in adults/adolescents.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2023)

Review Oncology

Urine biomarkers in cancer detection: A systematic review of preanalytical parameters and applied methods

Stephanie Jordaens, Karen Zwaenepoel, Wiebren Tjalma, Christophe Deben, Koen Beyers, Vanessa Vankerckhoven, Patrick Pauwels, Alex Vorsters

Summary: This review aimed to explore the use of urine sampling as a liquid biopsy for noninvasive cancer research. The analysis found that many publications did not report the preanalytical parameters of urine samples, despite the importance of standardization. Urine is being used for various cancer types and contains different analytes. Standard practice protocols and further research are needed to enhance the clinical utility of urine in cancer research and detection.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Health Care Sciences & Services

Academic detailing as a method to improve general practitioners' drug prescribing in type 2 diabetes: evaluation of changes in prescribing

Harald Christian Langaas, Oyvind Salvesen, Roar Dyrkorn, Hege Salvesen Blix, Olav Spigset

Summary: An academic detailing intervention was found to increase the utilization of metformin and improve the prescription patterns of other type 2 diabetes medications. However, for a complex subject like type 2 diabetes, more time should be reserved for the visit.

SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2023)

Article Medicine, General & Internal

Validation of a rapid SARS-CoV-2 antibody test in general practice

Julie Domen, Jan Yvan Jos Verbakel, Niels Adriaenssens, Beatrice Scholtes, Bart Peeters, Robin Bruyndonckx, An De Sutter, Stefan Heytens, Ann van den Bruel, Isabelle Desombere, Pierre Van Damme, Herman Goossens, Laetitia Buret, Els Duysburgh, Samuel Coenen

Summary: A study validated a rapid serological test for SARS-CoV-2 antibodies in healthcare providers in Belgium. The results showed that the test underestimated or overestimated the true seroprevalence in the population.

BMJ OPEN (2023)

Review Medicine, General & Internal

Safety and Efficacy of Different Anticoagulant Doses for Patients with COVID-19 in the ICU: A Systematic Review and Meta-Analysis

Svetlana Rachina, Yuliya Belkova, Anastasia Shchendrygina, Aleksandr Suvorov, Denis Bourgeois, Marina Karuk, Violetta Sitnikova, Nikita Dyatlov

Summary: This systematic review and meta-analysis aimed to evaluate the efficacy and safety of prophylactic, intermediate, and therapeutic dose anticoagulation in critically ill COVID-19 patients admitted to the ICU. The analysis showed that the different dosing regimens had no significant impact on short-term mortality and venous thromboembolism incidence, but had an effect on pulmonary embolism occurrence.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Infectious Diseases

Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries

Akke Vellinga, Addiena Luke-Currier, Nathaly Garzon-Orjuela, Rune Aabenhus, Marilena Anastasaki, Anca Balan, Femke Boehmer, Valerija Bralic Lang, Slawomir Chlabicz, Samuel Coenen, Ana Garcia-Sangenis, Anna Kowalczyk, Lile Malania, Angela Tomacinschii, Sanne R. van der Linde, Emily Bongard, Christopher C. Butler, Herman Goossens, Alike W. van der Velden

Summary: This study examined the antibiotic prescribing for respiratory tract infections in general practices across European countries. The findings showed that some countries did not meet the appropriate prescribing standards for certain types of infections, and the antibiotic usage rates differed among countries, with Denmark and Spain having lower rates compared to others.

ANTIBIOTICS-BASEL (2023)

Article Health Care Sciences & Services

Antibiotics for lower respiratory tract infection in children presenting in primary care: ARTIC-PC RCT

Paul Little, Nick A. Francis, Beth Stuart, Gilly O'Reilly, Natalie Thompson, Taeko Becque, Alastair Hay, Kay Wang, Michael Sharland, Anthony Harnden, Guiqing Yao, James Raftery, Shihua Zhu, Joseph Little, Charlotte Hookham, Kate Rowley, Joanne Euden, Kim Harman, Samuel Coenen, Robert C. Read, Catherine Woods, Christopher C. Butler, Saul N. Faust, Geraldine Leydon, Mandy Wan, Kerenza Hood, Jane Whitehurst, Samantha Richards-Hall, Peter Smith, Michael Thomas, Michael Moore, Theo Verheij

Summary: This study aims to evaluate the clinical effectiveness and cost-effectiveness of amoxicillin for uncomplicated lower respiratory tract infections in children. The results show that amoxicillin has no significant impact on clinical symptoms and resource utilization. It is suggested that parents and clinicians need better access to information and communication.

HEALTH TECHNOLOGY ASSESSMENT (2023)

Article Infectious Diseases

Impact of the COVID-19 pandemic on community antibiotic consumption in the EU/European Economic Area: a changepoint analysis

Helene Vermeulen, Niel Hens, Lucy Catteau, Boudewijn Catry, Samuel Coenen

Summary: A significant decrease in community antibiotic consumption in Europe was observed during the COVID-19 pandemic, with a decrease in seasonal variation as well.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Review Cardiac & Cardiovascular Systems

REVIEW OF INTERNATIONAL AND EUROPEAN REGISTERS ON INFECTIVE ENDOCARDITIS

K. P. Haralampova, N. A. Cherkasova, S. A. Rachina, S. M. Nasruloeva

Summary: This article examines international and European registries of infectious endocarditis and the observational studies based on them. It analyzes the methods of data collection, results, and conclusions. The prospects of using the registries for research, improving healthcare quality, and estimating costs are discussed.

KARDIOLOGIYA (2023)

Article Immunology

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults

Bruno Salaun, Jonathan De Smedt, Charlotte Vernhes, Annick Moureau, Deniz Oner, Arangassery Rosemary Bastian, Michel Janssens, Sunita Balla-Jhagjhoorsingh, Jeroen Aerssens, Christophe Lambert, Samuel Coenen, Christopher C. Butler, Simon B. Drysdale, Joanne G. Wildenbeest, Andrew J. Pollard, Peter J. M. Openshaw, Louis Bont, RESCEU Investigators

Summary: Cellular immunity plays a primary role in preventing symptomatic RSV infections in older adults, according to a study. T-cell data were found to be more predictive of RSV infection than functional antibody data.

FRONTIERS IN IMMUNOLOGY (2023)

Article Infectious Diseases

Bibliometric Analysis of Global Research Output on Antimicrobial Resistance among Pneumonia Pathogens (2013-2023)

Nurgul Ablakimova, Gaziza A. Smagulova, Svetlana Rachina, Aigul Z. Mussina, Afshin Zare, Nadiar M. Mussin, Asset A. Kaliyev, Reza Shirazi, Nader Tanideh, Amin Tamadon

Summary: This study conducts a bibliometric analysis of research on antimicrobial resistance (AMR) among pneumonia pathogens from 2013 to 2023. The findings reveal an increase in research output and emphasize the importance of collaborative studies. The analysis also identifies key journals, leading countries and institutions, as well as common microorganisms. It underscores the significance of knowledge dissemination and evidence-based interventions in addressing this public health challenge.

ANTIBIOTICS-BASEL (2023)

Article Infectious Diseases

Microbial Landscape and Antibiotic-Susceptibility Profiles of Microorganisms in Patients with Bacterial Pneumonia: A Comparative Cross-Sectional Study of COVID-19 and Non-COVID-19 Cases in Aktobe, Kazakhstan

Nurgul Ablakimova, Aigul Z. Mussina, Gaziza A. Smagulova, Svetlana Rachina, Meirambek S. Kurmangazin, Aigerim Balapasheva, Dinara Karimoldayeva, Afshin Zare, Mahdi Mahdipour, Farhad Rahmanifar

Summary: This cross-sectional study examined the microbial landscape and antibiotic resistance patterns in patients with bacterial pneumonia, specifically investigating the impact of COVID-19. Sputum samples from individuals with bacterial pneumonia, including COVID-19 positive and negative patients, were analyzed. The study found a low isolation rate of Streptococcus pneumoniae, a classic cause of bacterial pneumonia, in the sputum samples, and a higher frequency of multidrug-resistant pathogens in non-COVID-19 patients, suggesting the potential influence of the pandemic on antimicrobial resistance.

ANTIBIOTICS-BASEL (2023)

Article Infectious Diseases

Improved Diagnostics in Bacterial Neonatal Meningitis Using a Next-Generation Sequencing Platform

Alieke van der Hoeven, Martha T. van der Beek, Vincent Bekker, Erin Meijers, Marco J. R. Ivens, Els Wessels, Aloysius C. M. Kroes, Stefan A. Boers

Summary: Bacterial meningitis in infants is a life-threatening condition, and conventional bacterial culture may not always detect the causative microorganisms. The addition of 16S rRNA sequencing greatly improves the identification of bacterial meningitis.

INFECTIOUS DISEASES AND THERAPY (2023)

暂无数据